Comorbidity of eating disorders with bipolar disorder and treatment implications

Bipolar Disorders

Volumn 8, Issue 6, 2006, Pages 686-695

  McElroy, Susan L ^a   Kotwal, Renu ^a   Keck, Paul E ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Bipolar disorder; Comorbidity; Eating disorders

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; LITHIUM; MOOD STABILIZER; OLANZAPINE; RISPERIDONE; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

ANOREXIA NERVOSA; BINGE EATING DISORDER; BIPOLAR DISORDER; BULIMIA; CLINICAL TRIAL; COMORBIDITY; DRUG BLOOD LEVEL; EATING DISORDER; EVIDENCE BASED MEDICINE; HUMAN; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; REVIEW; TREATMENT PLANNING;

ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; COMORBIDITY; EATING DISORDERS; FRUCTOSE; HUMANS; IMPULSE CONTROL DISORDERS; ISOXAZOLES;

EID: 34249982460     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2006.00401.x     Document Type: Review

References (112)

1. Keck Jr PE, Perlis RH, Otto MW et al. The Expert Consensus Guideline Series: Treatment of Bipolar Disorder 2004. Postgrad Med Special Report 2004; December: 1-120.
2. McElroy SL, Kotwal R, Keck PE Jr, Akiskal HS. Comorbidity of bipolar disorder and eating disorders: Distinct or related disorders with shared dysregulations? J Affect Disord 2005; 86: 107-127.
3. Joyce P, Luty SE, McKenzie JM et al. Bipolar II disorder: Personality and outcome in two clinical samples. Aust N Z J Psychiatry 2004; 38: 433-438.
4. McElroy SL, Altshuler LL, Suppes T et al. Axis I psychiatric comorbidity and its relationship with historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry 2001; 158: 420-426.
5. Kessler RC, McGonagle KA, Zhao S et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51: 8-19.
6. Boyd JH, Burke JD, Gruenberg E et al. Exclusion criteria of DSM-III: A study of co-occurrence of hierarchy free syndromes. Arch Gen Psychiatry 1984; 41: 983-989.
7. Bulik CM, Sullivan PF, Slof MCT. Comorbidity of eating disorders and substance-related disorders. In: Kranzler HR, Tinsey JA eds. Dual Diagnosis and Psychiatric Treatment: Substance Abuse and Comorbid Disorders. New York: Marcel Dekker, 2004: 317-348.
8. Garfinkel PE, Lin E, Goering P et al. Bulimia nervosa in a Canadian community sample: Prevalence and comparison of subgroups. Am J Psychiatry 1995; 152: 1052-1058.
9. Braun DL, Sunday SR, Halmi KA. Psychiatric comorbidity in patients with eating disorders. Psychol Med 1994; 24: 859-867.
10. Halmi KA, Eckert E, Marchi P et al. Comorbidity of psychiatric diagnoses in anorexia nervosa. Arch Gen Psychiatry 1991; 48: 712-718.
11. Mury M, Verdoux H, Bourgeois M. Comorbidity of bipolar and eating disorders. Epidemiologic and therapeutic aspects. Encephale 1995; 21: 545-553.
12. Shisslak CM, Perse T, Crago M et al. Coexistence of bulimia nervosa and mania: A literature review and case series. Compr Psychiatry 1991; 32: 181-184.
13. Judd LL, Akiskal HS. The prevalence and disability of bipolar spectrum disorders in the US population: Re-analysis of the ECA database taking into account subthreshold cases. J Affect Disord 2003; 73: 123-131.
14. Crow SJ, Agras WS, Halmi K et al. Full syndromal versus subthreshold anorexia nervosa, bulimia nervosa, and binge eating disorder: A multicenter study. Int J Eat Disord 2002; 32: 309-318.
15. Angst J. The emerging epidemiology of hypomania and bipolar II disorder. J Affect Disord 1998; 50: 143-151.
16. Shisslak CM, Crago M, Estes LS. The spectrum of eating disturbances. Int J Eat Disord 1995; 18: 209-219.
17. Fogarty F, Russell JM, Newman SC et al. Mania. Acta Psychiatr Scand 1994; 376 (Suppl.): 16-23.
18. Wittchen H-U, Muhlig S, Pezawas L. Natural course and burden of bipolar disorders. Int J Neuropsychopharmacol 2003; 6: 145-154.
19. Lewinsohn PM, Shankman SA, Gau JM. The prevalence and comorbidity of subthreshold psychiatric conditions. Psychol Med 2004; 34: 613-622.
20. Spaner D, Bland RC, Newman SC. Major depressive disorder. Acta Psychiatr Scand 1994; 376 (Suppl.): 7-15.
21. Lewinsohn PM, Hops H, Roberts H et al. Adolescent psychopathology: I. Prevalence and incidence of depression and other DSM-III-R disorders in high school students. J Abnorm Psychol 1993; 102: 133-144.
22. Lewinsohn PM, Klein DN, Seeley JR. Bipolar disorders in a community sample of older adolescents: Prevalence, phenomenology, comorbidity, and course. J Am Acad Child Adolesc Psychiatry 1995; 34: 454-463.
23. Lewinsohn PM, Streigel-Moore RH, Seeley JR. Epidemiology and natural history of eating disorders in young women from adolescence to young adulthood. J Am Acad Child Adolesc Psychiatry 2000; 39: 1284-1292.
24. Lewinsohn PM, Seeley JR, Klein ON. Bipolar disorders during adolescence. Acta Psychiatr Scand 2003; 418 (Suppl.): 47-50.
25. Faedda GL, Baldessarini RJ, Glovinsky IP et al. Pediatric bipolar disorder: Phenomenology and course of illness. Bipolar Disord 2004; 6: 305-313.
26. Akiskal HS, Downs J, Jordan P et al. Affective disorders in the referred children and younger siblings of manic-depressives: Mode of onset and prospective course. Arch Gen Psychiatry 1985; 42: 996-1003.
27. MacQueen GM, Marriott M, Begin H et al. Subsyndromal symptoms assessed in longitudinal, prospective follow-up of a cohort of patients with bipolar disorder. Bipolar Disord 2003; 5: 349-355.
28. Pini N, Dell'Osso L, Mastrocinque C et al. Axis I comorbidity in bipolar disorder with psychotic features. Br J Psychiatry 1999; 56: 467-471.
29. Edmonds LK, Mosley BJ, Admiraal AJ et al. Familial bipolar disorder: preliminary results from the Otago Familial Bipolar Genetic Study. Aust N Z J Psychiatry 1998; 32: 823-829.
30. Cassano GB, Pini S, Saettoni M et al. Occurrence and clinical correlates of psychiatric comorbidity in patients with psychotic disorders. J Clin Psychiatry 1998; 59: 60-68.
31. Schuckit MA, Tipp JE, Anthenelli RM et al. Anorexia nervosa and bulimia nervosa in alcohol-dependent men and women and their relatives. Am J Psychiatry 1996; 153: 74-82.
32. Kruger S, Shugar G, Cooke RG. Comorbidity of binge eating disorder and the partial binge eating syndrome with bipolar disorder. Int J Eat Disord 1996; 19: 45-52.
33. McElroy SL, Strakowski SM, Keck PE Jr et al. Differences and similarities in mixed and pure mania. Compr Psychiatry 1995; 36: 187-194.
34. Strakowski SM, Tohen M, Stoll AL et al. Comorbidity in psychosis at first hospitalization. Am J Psychiatry 1993; 150: 752-757.
35. Strakowski SM, Tohen M, Stoll AL et al. Comorbidity in mania at first hospitalization. Am J Psychiatry 1992; 149: 554-556.
36. Vieta E, Colom F, Corbella B et al. Clinical correlates of psychiatric comorbidity in bipolar I patients. Bipolar Disord 2001; 3: 253-258.
37. Ramacciotti CE, Paoli RA, Marcacci G et al. Relationship between bipolar illness and binge-eating disorders. Psychiatry Res 2005; 135: 165-170.
38. Fontenelle LF, Mendlowicz MV, deMenezes GB et al. Psychiatric comorbidity in a Brazilian sample of patients with binge-eating disorder. Psychiatr Res 2003; 119: 189-194.
39. McElroy SL, Arnold LM, Shapira NA et al. Topiramate in the treatment of binge eating disorder with obesity: A randomized, placebo-controlled trial. Am J Psychiatry 2003; 160: 255-261.
40. Ivarsson T, Rastam M, Wentz E et al. Depressive disorders in teenage-onset anorexia nervosa: A controlled longitudinal, partly community-based study. Compr Psychiatry 2000; 41: 398-403.
41. Iwasaki Y, Matsunaga H, Kiriike N et al. Comorbidity of axis I disorders among eating-disordered subjects in Japan. Compr Psychiatry 2000; 41: 454-460.
42. Telch CF, Stice E. Psychiatric comorbidity in women with binge eating disorder: Prevalence rates from a non-treatment seeking sample. J Consult Clin Psychol 1998; 66: 768-776.
43. Lilenfeld LR, Kaye WH, Greeno CG et al. A controlled family study of anorexia nervosa and bulimia nervosa. Psychiatric disorders in first-degree relatives and effects of proband comorbidity. Arch Gen Psychiatry 1998; 55: 603-610.
44. Lilenfeld LR, Kaye WH, Greeno CG et al. Psychiatric disorders in women with bulimia nervosa and their first-degree relatives: Effects of comorbid substance dependence. Int J Eat Disord 1997; 22: 253-264.
45. Grilo CM, Levy KN, Becker DF et al. Comorbidity of DSM-III-R Axis I and II disorders among female inpatients with eating disorders. Psychiatr Serv 1996; 47: 426-429.
46. Brewerton TD, Lydiard B, Herzog DB et al. Comorbidity of Axis I psychiatric disorders in bulimia nervosa. J Clin Psychiatry 1995; 56: 77-80.
47. Specker S, deZwaan M, Raymond N et al. Psychopathology in subgroups of obese women with and without binge eating disorder. Compr Psychiatry 1994; 35: 185-190.
48. Bushnell JA, Wells JE, McKenzie JM et al. Bulimia comorbidity in the general population and the clinic. Psychol Med 1994; 24: 605-611.
49. Yanovski SZ, Nelson JE, Dubbert BK et al. Association of binge eating disorder and psychiatric comorbidity in obese subjects. Am J Psychiatry 1993; 150: 1472-1479.
50. Simpson SG, al-Mufti R, Andersen AE et al. Bipolar II affective disorder in eating disorder inpatients. J Nerv Ment Dis 1992; 180: 719-722.
51. Eddy KT, Keel PK, Dorer DJ et al. Longitudinal comparison of anorexia nervosa subtypes. Int J Eat Disord 2002; 31: 191-201.
52. Herzog DB, Keller MB, Sacks NR et al. Psychiatric comorbidity in treatment-seeking anorexics and bulimics. J Am Acad Child Adolesc Psychiatry 1992; 31: 810-818.
53. Keck PE Jr, Pope HG Jr, Hudson JI et al. A controlled study of phenomenology and family history in outpatients with bulimia nervosa. Compr Psychiatry 1990; 31: 275-283.
54. Toner BB, Garfinkel PE, Garner DM. Affective and anxiety disorders in the long-term follow-up of anorexia nervosa. Int J Psychiatry Med 1988; 18: 357-364.
55. Hudson JI, Pope HG Jr, Wurtman J et al. Bulimia in obese individuals. Relationship to normal weight bulimia. J Nerv Ment Dis 1988; 176: 144-152.
56. Hudson JI, Pope HG Jr, Yurgelun-Todd D et al. A controlled study of lifetime prevalence of affective and other psychiatric disorders in bulimic outpatients. Am J Psychiatry 1987; 144: 1283-1287.
57. Hudson JI, Pope HG Jr, Jonas JM et.al. A controlled family history study of bulimia. Psychol Med 1987; 17: 883-890.
58. Powers PS, Coovert DL, Brightwell DR et al. Other psychiatric disorders among bulimic patients. Compr Psychiatry 1988; 29: 503-508.
59. Walsh BT, Roose SP, Glassman AH et al. Bulimia and depression. Psychosom Med 1985; 47: 123-131.
60. Piran N, Kennedy S, Garfinkel PE et al. Affective disturbance in eating disorders. J Nerv Ment Dis 1985; 173: 395-400.
61. Stern SL, Dixon KN, Nemzer E et al. Affective disorder in the families of women with normal weight bulimia. Am J Psychiatry 1984; 141: 1224-1227.
62. Gershon ES, Schreiber JL, Hamovit JR et al. Clinical findings in patients with anorexia nervosa and affective illness in their relatives. Am J Psychiatry 1984; 141: 1419-1422.
63. Hudson JI, Pope HG Jr, Jonas JM et al. Phenomenologic relationship of eating disorders to major affective disorder. Psychiatr Res 1983; 9: 345-354.
64. Kringlen E, Torgerson S, Cramer V. A Norwegian psychiatric epidemiological study. Am J Psychiatry 2001; 158: 1091-1098.
65. Bijl RV, Ravelli A, Van Zessen G. Prevalence of psychiatric disorder in the general population: Results of the Netherlands Mental Health Survey and Incidence Study (NEM-ESIS). Soc Psychiatry Psychiatr Epidemiol 1998; 33: 587-595.
66. Wittchen H-U, Nelson CB, Lachner G. Prevalence of mental disorders and psychosocial impairments in adolescents and young adults. Psycho Med 1998; 28: 109-126.
67. Wells JE, Bushnell JA, Hornblow AR et al. Christchurch Psychiatric Epidemiology Study: Part 1. Methodology and lifetime prevalence for specific psychiatric disorders. Aust N Z J Psychiatry 1989; 23: 315-326.
68. Spitzer RL, Yanovski S, Wadden TB et al. Binge eating disorder: Its further validation in a multisite study. Int J Eat Disord 1993; 13: 137-153.
69. Smith DE, Marcus MD, Lewis CE et al. Prevalence of binge eating disorder, obesity, and depression in a biracial cohort of young adults. Ann Behav Med 1998; 20: 227-232.
70. Dingemans AE, Bruna MJ, van Furth EF. Binge eating disorder: A review. Int J Obes 2002; 26: 299-307.
71. Kessler RC, Chiu WT, Demler O et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 617-627.
72. Bulik CM, Klump KL, Thornton L et al. Alcohol use disorder comorbidity in eating disorders: A multicenter study. J Clin Psychiatry 2004; 65: 1000-1006.
73. Kaye WH, Bulik CM, Thornton L et al. Comorbidity of anxiety disorders with anorexia and bulimia nervosa. Am J Psychiatry 2004; 161: 2215-2221.
74. Gross HA, Ebert MH, Marchi P et al. A double-blind controlled trial of lithium carbonate in primary anorexia nervosa. J Clin Psychopharmacol 1981; 1: 376-381.
75. Hsu LKG, Clement L, Santhouse R et al. Treatment of bulimia nervosa with lithium carbonate. A controlled study. J Nerv Ment Dis 1991; 179: 351-355.
76. Kaplan AS, Garfinkel PE, Darby PL et al. Carbamazepine in the treatment of bulimia. Am J Psychiatry 1983; 140: 1225-1226.
77. Hudson JI, Pope HG Jr, Jonas JM et al. Treatment of anorexia nervosa with antidepressants. J Clin Psychopharmacol 1985; 5: 17-23.
78. Stein GS, Hartshorn S, Jones J et al. Lithium in a case of severe anorexia nervosa. Br J Psychiatry 1982; 140: 526-528.
79. Barcai A. Lithium in adult anorexia: A pilot report on two patients. Acta Psychiatr Scand 1977; 55: 97-101.
80. Reilly PP. Lithium administration has contributed to the management of anorexia nervosa. Rhode Isl Med J 1997; 56: 455-456.
81. Malina A, Gaskill J, McConaha C et al. Olanzapine treatment of anorexia nervosa: A retrospective study. Int J Eat Disord 2003; 33: 234-237.
82. Powers PS, Santana CA, Bannon YS. Olanzapine in the treatment of anorexia nervosa: An open-label trial. Int J Eat Disord 2002; 32: 146-152.
83. Boachie A, Goldfield GS, Spettigue W. Olanzapine use as an adjunctive treatment for hospitalized children with anorexia nervosa: Case reports. Int J Eat Disord 2002; 33: 98-103.
84. Mehler C, Wewetzer CH, Schulze V et.al. Olanzapine in children and adolescents with chronic anorexia. A study of five cases. Eur Child Adolesc Psychiatry 2001; 10: 151-157.
85. Newman-Toker J. Risperidone in anorexia nervosa. J Am Acad Child Adolesc Psychiatry 2000; 39: 941-942.
86. Jensen VS, Mejlhede A. Anorexia nervosa: Treatment with olanzapine. Br J Psychiatry 2000; 177: 87.
87. Hansen L. Olanzapine in the treatment of anorexia nervosa. Br J Psychiatry 1999; 175: 592.
88. Hsu LKG. Treatment of bulimia with lithium. Am J Psychiatry 1984; 141: 1260-1262.
89. Hsu LKG. Lithium in the treatment of eating disorders. In: Garfinkel PE, Garner DE eds. The Role of Drug Treatments for Eating Disorders. New York: Brunner/Mazel, 1987: 90-95.
90. Pope HG Jr, Hudson JI, Jonas JM. Bulimia in men: A series of 15 cases. J Nerv Ment Dis 1986; 174: 17-119.
91. Leyba CM, Gold DD. The relation between rapid-cycling cyclothymia and bulimia: Case reports of two women. SDJ Med 1988; 41: 21-22.
92. Herridge PL, Pope HG Jr. Treatment of bulimia and rapid cycling bipolar disorder with sodium valproate. J Clin Psychopharmacol 1985; 5: 229-230.
93. Shapira NA, Goldsmith TD, McElroy SL. Treatment of binge eating disorder with topiramate: A clinical case series. J Clin Psychiatry 2000; 61: 368-372.
94. Brewerton TD, Shannon M. Possible clozapine exacerbation of bulimia nervosa. Am J Psychiatry 1992; 149: 1408-1409.
95. Paquet V, Strul J, Servais L et al. Sleeping-related eating disorder induced by olanzapine. J Clin Psychiatry 2002; 63: 597.
96. Theisen FM, Linden A, Konig IR et al. Spectrum of binge eating symptomatology in patients treated with clozapine and olanzapine. J Neural Transm 2003; 110: 111-121.
97. Bromel T, Blum WF, Ziegler A et al. Serum leptin levels increase rapidly after initiation of clozapine therapy. Mol Psychiatry 1998; 3: 76-80.
98. Crockford DN, Fisher G, Barker P. Risperidone, weight gain, and bulimia nervosa. Can J Psychiatry 1997; 42: 326-327.
99. Keck PE Jr, McElroy SL. Treatment of bipolar disorder. In: Schatzberg AF, Nemeroff CB eds. Textbook of Psychopharmacology, 3rd edn. Washington DC: American Psychiatric Publishing, Inc., 2004: 865-883.
100. Zhu AJ, Walsh BT. Pharmacologic treatment of eating disorders. Can J Psychiatry 2002; 47: 227-234.
101. Carter WP, Hudson JI, Lalonde JK et al. Pharmacologic treatment of binge eating disorder. Int J Eat Disord 2003; 34: 574-588.
102. Siegel DM. Bulimia, tricyclic antidepressants, and mania. Clin Pediatr 1989; 28: 123-126.
103. Kaye WH, Nagata T, Weltzin TE et al. Double-blind placebo-controlled administration of fluoxetine in restricting- and restricting-purging-type anorexia nervosa. Biol Psychiatry 2001; 49: 644-652.
104. McElroy SL, Keck PE Jr. Topiramate. In: Schatzberg AF, Nemeroff CB eds. Textbook of Psychopharmacology, 3rd edn. Washington, DC: American Psychiatric Publishing, Inc., 2004: 627-636.
105. McIntyre RS, Mancini DA, McCann S et al. Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: A preliminary single-blind study. Bipolar Disord 2002; 4: 207-213.
106. McElroy SL, Suppes T, Black D et al. Open-label adjunctive zonisamide in the treatment of bipolar disorders. J Clin Psychiatry 2005; 66: 617-624.
107. Hoopes S, Reimherr F, Hedges D et al. Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial; part 1. Improvement in binge and purge measures. J Clin Psychiatry 2003; 64: 1335-1341.
108. Bray GA, Hollander P, Klein S et al. A 6-month randomized, placebo-controlled dose-ranging trial of topiramate for weight loss in obesity. Obes Res 2003; 11: 722-733.
109. Li Z, Maglione M, Tu W et al. Meta-analysis: Pharmacologic treatment of obesity. Ann Intern Med 2005; 142: 532-546.
110. McElroy SL, Kotwal R, Hudson JI et al. Zonisamide in the treatment of binge eating disorder: An open-label, prospective study. J Clin Psychiatry 2004; 65: 50-56.
111. Gadde KM, Franciscy DM, Wagner HR et al. Zonisamide for weight loss in obese adults: A randomized, controlled trial. JAMA 2003; 289: 1820-1825.
112. Volkow ND, Wise RA. How can drug addiction help us understand obesity? Nat Neurosci 2005; 8: 555-560.